##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-Q
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 FOR THE TRANSITION PERIOD FROM  TO
 Commission file number 333-145939
 CLEANTECH BIOFUELS, INC.
  Delaware
    
    33-0754902(State or other jurisdiction of incorporation or organization)
    
    (I.R.S. Employer Identification No.)7386 Pershing Ave., University City, Missouri
    
    63130(Address of principal executive offices)
    
    (Zip Code)
 (314) 802-8670
 Yes þ No o
 Yes o No o
  Large accelerated filer o
    
    Accelerated filer o
    
    Non-accelerated filer o
    
    Smaller reporting company þ(Do not check if a smaller reporting company)
 Yes o No þ




---



##### 



CLEANTECH BIOFUELS, INC.
TABLE OF CONTENTS
 PAGEPART I Financial InformationItem 1 Financial Statements (Unaudited)
    
    
    3Balance Sheets  March 31, 2009 and December 31, 2008
    
    
    3Statements of Operations  Three months ended March 31, 2009 and 2008 and Inception to March 31, 2009
    
    
    4Statements of Stockholders Equity (Deficit)  March 31, 2009
    
    
    5Statements of Cash Flows  Three months ended March 31, 2009 and 2008 and Inception to March 31, 2009
    
    
    6Notes to Financial Statements
    
    
    8Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations
    
    
    16Item 3 Quantitative and Qualitative Disclosures About Market Risk
    
    
    24Item 4T Controls and Procedures
    
    
    25PART II Other InformationItem 1 Legal Proceedings
    
    
    25Item 1A Risk Factors
    
    
    26Item 2 Unregistered Sales of Equity Securities and Use of Proceeds
    
    
    26Item 3 Defaults upon Senior Securities
    
    
    26Item 4 Submission of Matters to a Vote of Security Holders
    
    
    26Item 5 Other Information
    
    
    26Item 6 Exhibits
    
    
    27Signatures
    
    
    28Index to Exhibits
    
    
    29Exhibit 31.1Exhibit 31.2Exhibit 32.1Exhibit 32.2
   2




---



##### Table of Contents



PART I. FINANCIAL INFORMATION
 
 Item 1. Financial Statements (Unaudited)
 CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
 
 BALANCE SHEET
 March 31,
    
    
    December 31,2009
    
    
    2008(unaudited)ASSETSCurrent assets:Cash and cash equivalents
    
    $
    19,082
    
    
    $
    96,617Prepaids and other current assets
    
    
    49,963
    
    
    
    68,34569,045
    
    
    
    164,962Property and equipment, net
    
    
    32,956
    
    
    
    18,826Non-current assets:Technology licenses
    
    
    2,021,782
    
    
    
    2,021,782Patents
    
    
    600,000
    
    
    
    600,000Total Assets
    
    $
    2,723,783
    
    
    $
    2,805,570LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)Current liabilities:Accounts payable
    
    $
    269,933
    
    
    $
    238,925Accrued interest
    
    
    44,517
    
    
    
    26,660Accrued professional fees and other
    
    
    129,600
    
    
    
    66,250Notes Payable, net
    
    
    638,370
    
    
    
    456,712Deferred revenue
    
    
    70,333
    
    
    
    Capital lease
    
    
    4,704
    
    
    
    4,649Total current liabilities
    
    
    1,157,457
    
    
    
    793,196Capital Lease
    
    
    4,919
    
    
    
    6,117Series A Convertible Debentures
    
    
    140,000
    
    
    
    140,000STOCKHOLDERS EQUITY (DEFICIT)Preferred stock, $0.001 par value; 10,000,000 authorized shares; no shares
issued or outstanding
    
    
    
    
    
    
    Common stock, $0.001 par value; 240,000,000 authorized shares;
61,392,253 and 61,270,153 shares issued and outstanding at
March 31, 2009 and December 31, 2008, respectively
    
    
    61,392
    
    
    
    61,270Additional paid-in capital
    
    
    4,804,922
    
    
    
    4,675,098Notes receivable  restricted common shares issued to Directors and Employees
    
    
    (164,807
    )
    
    
    (162,567
    )Deficit accumulated during the development stage
    
    
    (3,280,100
    )
    
    
    (2,707,544
    )Total Stockholders Equity
    
    
    1,421,407
    
    
    
    1,866,257Total Liabilities and Stockholders Equity
    
    $
    2,723,783
    
    
    $
    2,805,570
 See accompanying notes to financial statements.
  3




---



##### Table of Contents



CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
 
 STATEMENTS OF OPERATIONS (unaudited)
 July 14, 2004Three months ended
    
    
    (inception) toMarch 31,
    
    
    March 31,2009
    
    
    2008
    
    
    2009General and administrative
    
    $
    243,823
    
    
    $
    146,223
    
    
    $
    1,311,573Professional fees
    
    
    109,413
    
    
    
    111,946
    
    
    
    868,854Research and development
    
    
    101
    
    
    
    183,104
    
    
    
    524,802Operating Loss
    
    
    353,337
    
    
    
    441,273
    
    
    
    2,705,229Other expense (income):Interest expense
    
    
    226,127
    
    
    
    19,751
    
    
    
    472,585Amortization of technology license
    
    
    
    
    
    
    3,750
    
    
    
    35,000Deposit forfeiture
    
    
    
    
    
    
    
    
    
    
    (25,000
    )Other income
    
    
    (4,667
    )
    
    
    
    
    
    
    (4,667
    )Interest income
    
    
    (2,241
    )
    
    
    (5,727
    )
    
    
    (37,395
    )219,219
    
    
    
    17,774
    
    
    
    440,523Net loss applicable to common stockholders
    
    $
    572,556
    
    
    $
    459,047
    
    
    $
    3,145,752Basic and diluted net loss per common share
    
    $
    0.01
    
    
    $
    0.01
    
    
    $
    0.07Weighted average common shares outstanding
    
    
    61,351,553
    
    
    
    50,082,525
    
    
    
    45,050,374
 See accompanying notes to financial statements.
  4




---



##### Table of Contents



CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
 
 STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (unuaudited)
 Notes Rec -restrictedcommon
    
    
    July 14, 2004Additional
    
    
    shares issued
    
    
    (inception) toCommon Stock
    
    
    Paid-in
    
    
    to Directors
    
    
    March 31,Shares
    
    
    Amount
    
    
    Capital
    
    
    and Employees
    
    
    2009Balances at December 31, 2008
    
    
    61,270,153
    
    
    $
    61,270
    
    
    $
    4,675,098
    
    
    $
    (162,567
    )
    
    $
    (2,707,544
    )Conversion of convertible note in
February 2009 at $.25 per share
    
    
    122,100
    
    
    
    122
    
    
    
    11,533Discounts on Notes Payable
    
    
    
    
    
    
    
    
    
    
    35,000Interest on Notes Receivable
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (2,240
    )Stock-based compensation
    
    
    
    
    
    
    
    
    
    
    83,291Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (572,556
    )Balances at March 31, 2009
    
    
    61,392,253
    
    
    $
    61,392
    
    
    $
    4,804,922
    
    
    $
    (164,807
    )
    
    $
    (3,280,100
    )
 See accompanying notes to financial statements.
  5




---



##### Table of Contents



CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
 
 STATEMENTS OF CASH FLOWS (Unaudited)
 July 14, 2004Three months ended
    
    
    (inception) toMarch 31,
    
    
    March 31,2009
    
    
    2008
    
    
    2009Operating ActivitiesNet loss applicable to common stockholders
    
    $
    (572,556
    )
    
    $
    (459,047
    )
    
    $
    (3,145,752
    )Adjustments to reconcile net loss applicable to common
stockholders to net cash used by operating activities:Items that did not use (provide) cash:Common stock issued for organizational costs
    
    
    
    
    
    
    
    
    
    
    100Depreciation
    
    
    1,070
    
    
    
    4,909
    
    
    
    29,898Amortization
    
    
    
    
    
    
    3,750
    
    
    
    35,000Interest income
    
    
    (2,240
    )
    
    
    
    
    
    
    (10,007
    )Amortization of discounts (interest expense) and
other financing charges
    
    
    207,401
    
    
    
    
    
    
    
    346,353Share-based compensation expense
    
    
    83,291
    
    
    
    82,680
    
    
    
    341,412Write-off of technology license
    
    
    
    
    
    
    
    
    
    
    97,500Fair value of RAM warrant settlement
    
    
    
    
    
    
    
    
    
    
    125,027Changes in operating assets and liabilities that provided
(used) cash, net:Prepaids and other current assets
    
    
    18,382
    
    
    
    11,581
    
    
    
    (49,963
    )Technology license
    
    
    
    
    
    
    
    
    
    
    (132,500
    )Accounts payable
    
    
    31,008
    
    
    
    71,538
    
    
    
    269,933Other assets and other liabilities
    
    
    88,836
    
    
    
    13,969
    
    
    
    164,367Accrued liabilities
    
    
    63,350
    
    
    
    
    
    
    
    129,600Net cash used by operating activities
    
    
    (81,458
    )
    
    
    (270,620
    )
    
    
    (1,799,032
    )Cash Flows Provided (Used) by Investing ActivitiesAcquisition of patent, net
    
    
    
    
    
    
    
    
    
    
    (150,000
    )Merger of Biomass North America Licensing, Inc., net
    
    
    
    
    
    
    
    
    
    
    (20,000
    )Acquisition of HFTA technology, net
    
    
    
    
    
    
    
    
    
    
    Expenditures for equipment
    
    
    (15,200
    )
    
    
    (26,680
    )
    
    
    (48,735
    )Net cash used by investing activities
    
    
    (15,200
    )
    
    
    (26,680
    )
    
    
    (218,735
    )Cash Flows Provided (Used) by Financing ActivitiesPayments on capital lease, including interest
    
    
    (1,264
    )
    
    
    (366
    )
    
    
    (5,051
    )Series A Convertible Debentures, including interest
    
    
    
    
    
    
    474,900
    
    
    
    1,424,900Issuance of Convertible Notes Payable
    
    
    35,000
    
    
    
    
    
    
    
    642,000Payments on Note Payable
    
    
    (14,613
    )
    
    
    
    
    
    
    (50,000
    )Sale of common stock
    
    
    
    
    
    
    
    
    
    
    25,000Net cash provided by financing activities
    
    
    19,123
    
    
    
    474,534
    
    
    
    2,036,849Net increase (decrease) in cash and cash equivalents
    
    
    (77,535
    )
    
    
    177,234
    
    
    
    19,082Cash and cash equivalents at beginning of period
    
    
    96,617
    
    
    
    120,356
    
    
    
    Cash and cash equivalents at end of period
    
    $
    19,082
    
    
    $
    297,590
    
    
    $
    19,082
  6




---



##### Table of Contents



CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
STATEMENTS OF CASH FLOWS contd
 July 14, 2004Three months ended
    
    
    (inception) toMarch 31,
    
    
    March 31,2009
    
    
    2008
    
    
    2009Supplemental
disclosure of cash
flow information:Cash paid for interest
    
    $
    345
    
    
    $
    
    
    
    $
    7,555Supplemental
disclosure of noncash
investing and
financing activities:Promissory notes receivable
related to Series A
Convertible Debentures
    
    $
    
    
    
    $
    
    
    
    $
    450,000Capital lease related to
the purchase of equipment
    
    $
    
    
    
    $
    
    
    
    $
    14,119Common stock issued for
organizational costs
    
    $
    
    
    
    $
    
    
    
    $
    100Common stock issued for
promissory notes
    
    $
    
    
    
    $
    
    
    
    $
    133,596Common stock issued for
Convertible notes converted
    
    $
    122,100
    
    
    $
    
    
    
    $
    122,100Common stock issued for
Debentures converted
    
    $
    
    
    
    $
    664,960
    
    
    $
    1,333,337Common stock and note
payable issued for
acquistion of Biomass
    
    $
    
    
    
    $
    
    
    
    $
    1,501,250Common stock issued for HFTA
    
    $
    
    
    
    $
    
    
    
    $
    500,532
 See accompanying notes to financial statements.
  7




---



##### Table of Contents



Note 1  Organization and Business
      Note 2  Interim Financial Statements
  Note 3  Mergers/Acquisitions
   8




---



##### Table of Contents



Note 4  Patent
  Note 5  Technology Licenses
 Biomass North America Licensing, Inc.
    9




---



##### Table of Contents



HFTA, Inc.
    Bio-Products International, Inc.
    10




---



##### Table of Contents



Brelsford Engineering, Inc.
   Note 6  Debt
 March 31,
    
    
    December 31,2009
    
    
    2008Convertible Notes Payable, net of discounts of $381,208 and $514,797
at March 31, 2009 and December 31, 2008, respectively, which are
made up of various individual notes with an aggregate face value
of
$612,000 and $607,000 at March 31, 2009 and December 31, 2008,
respectively, due in one year from date of note, interest at 6.0%
    
    $
    230,792
    
    
    $
    92,203WWT Note Payable, net of discount of $72,423 and $130,105 at
March 31, 2009 and December 31, 2008, respectively, with a face
value of $450,000, due July 22, 2009, interest at 6.0%
    
    
    377,577
    
    
    
    319,895Note Payable, due April 5, 2009, interest at 6.0%
    
    
    30,001
    
    
    
    44,614Series A Convertible Debentures, due April 16, 2010, interest at 6.0%
    
    
    140,000
    
    
    
    140,000Total debt
    
    
    778,370
    
    
    
    596,712Current maturities  Notes Payable, net
    
    
    (638,370
    )
    
    
    (456,712
    )Long-term portion, less current maturities
    
    $
    140,000
    
    
    $
    140,000
 Convertible Notes Payable
    11




---



##### Table of Contents



WWT Note Payable
  Note Payable
  Series A Convertible Debentures
    Note 7  Stockholders Deficit
       12




---



##### Table of Contents



Net
Loss per Common Share
 Note 8  Related Party Transactions
    Note 9  Share-based Payments
     13




---



##### Table of Contents



For the years ended December 31,2008
    
    
    2007Risk-free interest rate
    
    
    1.57
    %
    
    
    4.25
    %Dividend yield
    
    
    0
    %
    
    
    0
    %Volatility
    
    
    36.91
    %
    
    
    61.49
    %Expected term
    
    
    4.8
    
    
    
    5.0Fair market value
    
    $
    0.12
    
    
    $
    0.08
  Three months endedMar 31, 2009
    
    
    Mar 31, 2008Pre-tax compensation expense:Stock options
    
    $
    83,291
    
    
    $
    82,681Warrants
    
    
    
    
    
    
    Total expense
    
    
    83,291
    
    
    
    82,681Tax benefit, net
    
    
    
    
    
    
    After-tax compensation expense
    
    $
    83,291
    
    
    $
    82,681
   14




---



##### Table of Contents



WeightedShares Under
    
    
    Average
    
    
    AggregateOption
    
    
    Exercise Price
    
    
    intrinsic valueOptions outstanding at December 31, 2008
    
    
    6,510,000
    
    
    $
    0.20
    
    
    
    
    (1)Granted
    
    
    Exercised
    
    
    Forfeited
    
    
    Options outstanding at March 31, 2009
    
    
    6,510,000
    
    
    $
    0.20
    
    
    
    
    (1)Options exercisable at March 31, 2009
    
    
    1,396,666
    
    
    $
    0.16
    
    
    
    
    (1)
 (1)
    
    The weighted-average exercise price at December 31, 2008 and March 31, 2009 for all
outstanding
and exercisable options was greater than the fair value of the
Companys common stock on that date, resulting in an aggregate intrinsic value of $-0-. Note 10  Commitments and Contingencies
 Project management
  Duluth
Litigation
 Leases 
 Note 11  Subsequent Events
   15




---



##### Table of Contents



Item 2.
    
    Managements Discussion and Analysis of Financial Condition and Results of Operations
 Statement Regarding Forward-Looking Information
  
 
    
    the commercial viability of our technologies,
    
    our ability to maintain and enforce our exclusive rights to our technologies,
    
    our ability to raise additional capital on favorable terms to continue developing
our technologies;
    
    the demand for and production costs of various energy products made from our
biomass,
    
    competition from other alternative energy technologies, and
    
    other risks and uncertainties detailed from time to time in our filings with the
SEC.
  Company Overview
   16




---



##### Table of Contents




    
    a pressurized steam classification technology, which we refer to as the PSC
technology, invented at the University of Alabama, Huntsville that used a pressurized steam
classification vessel to convert MSW into cellulosic material while simultaneously
segregating and eliminating any inorganic materials in the solid waste and cleaning
recyclable materials in the MSW;
    
    a sulfuric acid hydrolysis process, which we refer to as the Brelsford technology,
developed by Brelsford Engineering, Inc. that employs an acid hydrolysis process to convert
cellulosic material into fermentable sugars, which can then be fermented into ethanol, and;
    
    a nitric acid hydrolysis process, which we refer to as our HFTA technology, developed
by scientists working at the University of California, Berkeley, that incorporates
anticipated improvements in chemical reaction by which acid hydrolysis occurs.
         17




---



##### Table of Contents



Recent Developments
   Plan of Operation
    18




---



##### Table of Contents



Biomass Feedstock Production
     Diesel Fuel Production
    19




---



##### Table of Contents



New Technologies; Commercializing Existing Technologies
   
    
    construct and operate a commercial plant that processes MSW into cellulosic biomass for
combustion in existing co-fired boilers for electricity production in Chicago, Illinois;
    
    identify and partner with landfill owners, waste haulers and municipalities to identify
locations suitable for our technology; and
    
    pursue additional opportunities to implement our technology in commercial settings at
transfer stations and landfills in the United States and elsewhere in the world.
  
    
    complete the research and development of our licensed technologies, which we believe
when combined can convert MSW into ethanol; and
    
    explore, develop and/or license additional technologies for processing waste into energy
products as opportunities to do so present themselves.
   20




---



##### Table of Contents



Results of Operations
  Three months endedMarch 31, 2009
    
    
    March 31, 2008
    
    
    ChangeGeneral and administrative
    
    $
    243,823
    
    
    $
    146,223
    
    
    $
    97,600Professional fees
    
    
    109,413
    
    
    
    111,946
    
    
    
    (2,533
    )Research and development
    
    
    101
    
    
    
    183,104
    
    
    
    (183,003
    )Operating loss
    
    
    353,337
    
    
    
    441,273
    
    
    
    (87,936
    )Other expense (income):Interest expense
    
    
    226,127
    
    
    
    19,751
    
    
    
    206,376Amortization of technology license
    
    
    
    
    
    
    3,750
    
    
    
    (3,750
    )Other income
    
    
    (4,667
    )
    
    
    
    
    
    
    (4,667
    )Interest income
    
    
    (2,241
    )
    
    
    (5,727
    )
    
    
    3,486Net loss applicable to common stockholders
    
    $
    572,556
    
    
    $
    459,047
    
    
    $
    113,509
 Three months ended March 31, 2009 compared to the three months ended March 31, 2008
 General and administrative
 Research and Development
 Interest expense
 Amortization
 Other income
 Interest income
 Liquidity and Capital Resources
   21




---



##### Table of Contents



Debt
 Convertible Notes Payable
  WWT Note Payable
  Note Payable
    22




---



##### Table of Contents



Series A Convertible Debentures
   Summary of Cash Flow Activity
 Three Months Ended March 31,2009
    
    
    2008Net cash used by operating activities
    
    $
    (81,458
    )
    
    $
    (270,620
    )Net cash used by investing activities
    
    
    (15,200
    )
    
    
    (26,680
    )Net cash provided by financing
activities
    
    
    19,123
    
    
    
    474,534
 Net cash used by operating activities
  Net cash used by investing activities
  Net cash provided by financing activities
   23




---



##### Table of Contents



Contractual Obligations and Commitments
  Payments due by PeriodLess than 1
    
    
    
    
    
    
    
    
    
    
    More than 5Total
    
    
    year
    
    
    1 to 3 years
    
    
    4 to 5 years
    
    
    yearsConvertible Notes (1)
    
    $
    650,000
    
    
    $
    650,000
    
    
    $
    
    
    
    $
    
    
    
    $
    WWT Note (2)
    
    
    470,250
    
    
    
    470,250
    
    
    
    
    
    
    
    
    
    
    
    Note Payable (2)
    
    
    31,900
    
    
    
    31,900
    
    
    
    
    
    
    
    
    
    
    
    Series A Convertible Debentures (3)
    
    
    140,000
    
    
    
    
    
    
    
    140,000
    
    
    
    
    
    
    
    Capital Lease (4)
    
    
    10,800
    
    
    
    5,400
    
    
    
    5,400
    
    
    
    
    
    
    
    Operating Lease (5)
    
    
    37,800
    
    
    
    21,600
    
    
    
    16,200
    
    
    
    
    
    
    
    Total contractual obligations
    
    $
    1,340,750
    
    
    $
    1,179,150
    
    
    $
    161,600
    
    
    $
    
    
    
    $
    
 (1)
    
    Amount represents value of principal amount of notes and estimates for interest. These notes
are with various
individuals, carry one-year terms and are convertible into shares of Common Stock at the
noteholders option. The first of
these notes are due October 1, 2009. If the noteholders do not convert their notes into shares of
Common Stock, the notes
will have to be repaid or refinanced.(2)
    
    Amount represents value of principal amount of note and interest through term of note.(3)
    
    Debentures are convertible at Companys option into shares of the Companys common stock.(4)
    
    Represents lease on office furniture.(5)
    
    Represents lease for office space. The lease is for three years from occupancy date of January
2008.  Merrick & Company.
 Off-Balance Sheet Arrangements
  Critical Accounting Policies
   
 Item 3. Quantitative and Qualitative Disclosures About Market Risk
   24




---



##### Table of Contents



Item 4T. Controls and Procedures
 Effectiveness of Disclosure Controls and Procedures
  Changes in Internal Control Over Financial Reporting
 
 PART II. OTHER INFORMATION
 
 Item 1. Legal Proceedings
 Duluth Venture Capital Partners, LLC v. Cleantech Biofuels, Inc., et al.
    Selling Stockholder
    
    Shares SuspendedBrite Star Associates, Inc.
    
    
    1,777,867Fountain Consulting, Inc.
    
    
    1,482,000St Ives Consulting, Inc.
    
    
    1,368,000Trinity Enterprises, L.L.C.
    
    
    1,966,667Padstow Estates, Inc.
    
    
    1,966,667
  25




---



##### Table of Contents



Ram Resources, L.L.C. v. CleanTech Biofuels, Inc.
 
 Item 1A. Risk Factors
  
 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
 Item 3. Defaults Upon Senior Securities 
 
 Item 4. Submission of Matters to a Vote of Security Holders 
 
 Item 5. Other Information 
  26




---



##### Table of Contents



Item 6. Exhibits
  EXHIBIT NO.
    
    DESCRIPTION31.1
    
    
    Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the
Securities Exchange Act, as amended.31.2
    
    
    Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of
the Securities Exchange Act, as amended.32.1
    
    
    Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Chief Executive Officer.32.2
    
    
    Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Principal Financial Officer.
  27




---



##### Table of Contents



SIGNATURES
  CLEANTECH BIOFUELS, INC.Date: May 15, 2009
    /s/ Edward P. Hennessey, Jr.Edward P. Hennessey, Jr.Chief Executive OfficerDate: May 15, 2009
    /s/ Thomas JenneweinThomas JenneweinChief Financial Officer and
Principal Accounting Officer  28




---



##### Table of Contents



INDEX TO EXHIBITS
 EXHIBIT NO.
    
    DESCRIPTION31.1
    
    
    Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the
Securities Exchange Act, as amended.31.2
    
    
    Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of
the Securities Exchange Act, as amended.32.1
    
    
    Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Chief Executive Officer.32.2
    
    
    Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Principal Financial Officer.
  29